JPMA Has “Different View” from US Govt on COVID-19 Vaccine IP Waiver

May 10, 2021
The Japan Pharmaceutical Manufacturers Association (JPMA) on May 7 released a statement on a WTO proposal to waive intellectual property rights for COVID-19 vaccines, taking issue with the US government’s surprising support for the bid expressed earlier in the week...read more